Please sign in to follow a disease.

Non-alcoholic steato-hepatitis (NASH)

Clinical trials for Non-alcoholic steato-hepatitis (NASH) explained in plain language.

Never miss a new study

Get alerted when new Non-alcoholic steato-hepatitis (NASH) trials appear

Sign up with your email to follow new studies for Non-alcoholic steato-hepatitis (NASH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Vitamin B3 shows promise in fighting fatty liver disease

Disease control Recruiting now

This study tests whether taking a low dose of niacin (vitamin B3) after meals can help reduce fat stored in the liver for people with metabolic fatty liver disease (MASLD). Researchers will compare niacin to a placebo in 36 adults aged 50 to 80. The goal is to see if niacin can r…

Matched conditions: NON-ALCOHOLIC STEATO-HEPATITIS (NASH)

Sponsor: Université de Sherbrooke • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC

Non-alcoholic steato-hepatitis (NASH)

Get alerted when new Non-alcoholic steato-hepatitis (NASH) trials appear

Vitamin B3 shows promise in fighting fatty liver disease